Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status
FOSB expression holds promise as a novel prognostic biomarker for NSCLC in combination with a given genetic background of TP53, and the unique interactions between FOSB and p53 may serve as underlying intervention targets for NSCLC.
Authors
- Su Cui
- Xiaobo Lu (ORCID: https://orcid.org/0000-0002-3136-9439)
- Shengwen Wu
- Mingyang Xiao (ORCID: https://orcid.org/0000-0003-0365-4133)
- Hongchao Zhang (ORCID: https://orcid.org/0000-0003-2716-3267)
- H. J. Yang (ORCID: https://orcid.org/0009-0004-8274-9863)
- Guopei Zhang (ORCID: https://orcid.org/0000-0002-4530-5954)
- Cuihong Jin (ORCID: https://orcid.org/0000-0002-9317-3538)
Institutions
- Shenyang Medical College (CN)
- Shenyang Center for Disease Control and Prevention (CN)
- Shanghai East Hospital (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Experimental & Clinical Cancer Research
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1186/s13046-024-03161-1
- Citations
- 14
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.27
Funders
- National Natural Science Foundation of China